DK2922571T3 - Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner - Google Patents

Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner

Info

Publication number
DK2922571T3
DK2922571T3 DK13801495.6T DK13801495T DK2922571T3 DK 2922571 T3 DK2922571 T3 DK 2922571T3 DK 13801495 T DK13801495 T DK 13801495T DK 2922571 T3 DK2922571 T3 DK 2922571T3
Authority
DK
Denmark
Prior art keywords
carboran
porphyrines
metallo
pharmaceutical formula
formula containing
Prior art date
Application number
DK13801495.6T
Other languages
English (en)
Inventor
Chris Beattie
James Rennie
Anne Wadsworth
Original Assignee
Morex Dev Partners Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morex Dev Partners Llp filed Critical Morex Dev Partners Llp
Application granted granted Critical
Publication of DK2922571T3 publication Critical patent/DK2922571T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK13801495.6T 2012-11-23 2013-11-22 Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner DK2922571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1221125.6A GB201221125D0 (en) 2012-11-23 2012-11-23 Pharmaceutial formulations
PCT/EP2013/074490 WO2014079977A1 (en) 2012-11-23 2013-11-22 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK2922571T3 true DK2922571T3 (da) 2017-11-13

Family

ID=47560584

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13801495.6T DK2922571T3 (da) 2012-11-23 2013-11-22 Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner

Country Status (20)

Country Link
US (1) US9358290B2 (da)
EP (1) EP2922571B1 (da)
JP (1) JP6279599B2 (da)
KR (1) KR20150086283A (da)
CN (1) CN104853777B (da)
CA (1) CA2890271A1 (da)
CY (1) CY1119713T1 (da)
DK (1) DK2922571T3 (da)
ES (1) ES2646010T3 (da)
GB (1) GB201221125D0 (da)
HR (1) HRP20171652T1 (da)
HU (1) HUE035198T2 (da)
LT (1) LT2922571T (da)
NO (1) NO2922571T3 (da)
PL (1) PL2922571T3 (da)
PT (1) PT2922571T (da)
RS (1) RS56499B1 (da)
SI (1) SI2922571T1 (da)
SM (1) SMT201700512T1 (da)
WO (1) WO2014079977A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201212409D0 (en) * 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925736A (en) 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
JP2005513001A (ja) 2001-11-09 2005-05-12 キュー エル ティー インク． 脱毛治療のための光力学療法
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
EP2194027A4 (en) * 2007-09-03 2011-04-27 Kawamura Inst Chem Res METHOD FOR PRODUCING A STRUCTURE COATED WITH A NANOSTRUCTURE COMPOSITE, A STRUCTURE COATED WITH A NANOSTRUCTURE COMPOUND AND A NANOSTRUCTURED COMPOSITE STRUCTURE REACTOR
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
GB201212409D0 (en) * 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment

Also Published As

Publication number Publication date
NO2922571T3 (da) 2018-02-03
SI2922571T1 (sl) 2017-12-29
CA2890271A1 (en) 2014-05-30
EP2922571A1 (en) 2015-09-30
HRP20171652T1 (hr) 2017-12-15
PT2922571T (pt) 2017-11-07
RS56499B1 (sr) 2018-01-31
LT2922571T (lt) 2017-11-10
GB201221125D0 (en) 2013-01-09
KR20150086283A (ko) 2015-07-27
EP2922571B1 (en) 2017-09-06
CN104853777B (zh) 2019-03-08
SMT201700512T1 (it) 2018-01-11
WO2014079977A1 (en) 2014-05-30
JP2016500090A (ja) 2016-01-07
ES2646010T3 (es) 2017-12-11
PL2922571T3 (pl) 2018-03-30
US9358290B2 (en) 2016-06-07
CN104853777A (zh) 2015-08-19
CY1119713T1 (el) 2018-06-27
JP6279599B2 (ja) 2018-02-14
US20150297717A1 (en) 2015-10-22
HK1209339A1 (en) 2016-04-01
HUE035198T2 (hu) 2018-05-02

Similar Documents

Publication Publication Date Title
CY2022027I1 (el) Παραγωγα βενζιμιδαζολο-προλινης
HRP20171005T1 (hr) Spojevi imidazopirolidinona
DK3858405T3 (da) Sprøjte
DK3656373T3 (da) Sprøjte
BR112015002738A2 (pt) composto , e , composição farmacêutica
EP2832391A4 (en) SYRINGE
HRP20170226T1 (hr) Spoj pirazinkarboksamida
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
IL239447A0 (en) Novel compounds
DK2804611T3 (da) Chitosanafledte forbindelser
DK2897594T3 (da) Farmaceutisk sammensætning
CL2014003283A1 (es) Formulación farmacéutica.
EP2913076A4 (en) SYRINGE
EP2883547A4 (en) MEDICINE
DK2854765T3 (da) Farmaceutisk pemetrexed-opløsning
DK2851075T3 (da) Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
SMT201600419B (it) Composizione farmaceutica contenente fosfolipidi
LT2908836T (lt) Farmacinė kompozicija, turinti kurkumino
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
BR302012003979S1 (pt) Configuração aplicada em fármaco
PL2922571T3 (pl) Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION
DE102012112916A8 (de) Dosiermodul
TH1301004215B (th) องค์ประกอบเชิงเภสัชกรรมซึ่งประกอบรวมด้วยอนุพันธ์ไพริโอน
UA25455S (uk) Флакон для лікарських засобів